BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Lv H, Zhang G. Hepatitis C virus core antigen assay: an alternative method for hepatitis C diagnosis. Ann Clin Biochem 2017;54:279-85. [PMID: 27614354 DOI: 10.1177/0004563216661218] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kallala O, Kacem S, Fodha I, Pozzetto B, Abdelhalim T. Role of hepatitis C virus core antigen assay in hepatitis C care in developing country. Egypt Liver J 2021;11:77. [PMID: 34777874 DOI: 10.1186/s43066-021-00146-z] [Reference Citation Analysis]
2 Pérez-garcía A, Aguinaga A, Navascués A, Castilla J, Ezpeleta C. Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virus. International Journal of Infectious Diseases 2019;89:131-6. [DOI: 10.1016/j.ijid.2019.09.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Sadeghimehr M, Bertisch B, Negro F, Butsashvili M, Shilton S, Tskhomelidze I, Tsereteli M, Keiser O, Estill J. Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis. PeerJ 2021;9:e11895. [PMID: 34595063 DOI: 10.7717/peerj.11895] [Reference Citation Analysis]
4 Wasitthankasem R, Vichaiwattana P, Auphimai C, Siripon N, Klinfueng S, Tangkijvanich P, Vongpunsawad S, Poovorawan Y. HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs. PeerJ 2017;5:e4008. [PMID: 29134150 DOI: 10.7717/peerj.4008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
5 Jiang X, Chang L, Yan Y, Ji H, Sun H, Guo F, Wang L. A study based on four immunoassays: Hepatitis C virus antibody against different antigens may have unequal contributions to detection. Virol J 2021;18:137. [PMID: 34217305 DOI: 10.1186/s12985-021-01608-x] [Reference Citation Analysis]
6 Adland E, Jesuthasan G, Downs L, Wharton V, Wilde G, McNaughton AL, Collier J, Barnes E, Klenerman P, Andersson M, Jeffery K, Matthews PC. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort. BMC Infect Dis 2018;18:461. [PMID: 30217169 DOI: 10.1186/s12879-018-3367-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
7 Hassanin TM, Abdelraheem EM, Abdelhameed S, Abdelrazik M, Fouad YM. Detection of hepatitis C virus core antigen as an alternative method for diagnosis of hepatitis C virus infection in blood donors negative for hepatitis C virus antibody. Eur J Gastroenterol Hepatol 2020;32:1348-51. [PMID: 31895913 DOI: 10.1097/MEG.0000000000001647] [Reference Citation Analysis]
8 Wang Y, Jie W, Ling J, Yuanshuai H. HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. J Clin Lab Anal 2021;35:e23755. [PMID: 33788295 DOI: 10.1002/jcla.23755] [Reference Citation Analysis]